ASSIGNMENT AND ASSET PURCHASE AGREEMENT by and betweenAssignment and Asset Purchase Agreement • June 7th, 2021 • Unicycive Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 7th, 2021 Company Industry JurisdictionThis ASSIGNMENT AND ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of September 20, 2018 (the “Effective Date”), by and between Unicycive Therapeutics, Inc., a Delaware corporation, having a principal place of business at 5150 El Camino Real, Suite #A-32, Los Altos, CA 94022 (the “Purchaser”) and Spectrum Pharmaceuticals, Inc., a Delaware corporation, with corporate headquarters at 11500 S. Eastern Ave., Henderson, NV 89052 (the “Seller”). The Purchaser and the Seller are sometimes referred to in this Agreement individually as a “Party” and collectively as the “Parties.”